BlackBio signs JV agreement in India to develop, manufacture and commercialize new integral solutions for diagnostics
2B BlackBio, S.L. has signed with its local partner in India, Kilpest Ltd an agreement to participate in the `recently established joint venture between Kilpest and Biotools B&M Labs, S.A., renamed now as 3B BlackBio Biotech India Ltd´. With this agreement the new JV with laboratories in Bhopal, and Headquarters in Mumbai, India, will manufacture and develop integral solutions in the area of Personalized medicine and will offer diagnostic tests to predict drug treatment effectiveness (Companion Diagnostics), providing technologies to participate in the present exponential development of the Indian Pharma sector.
Together with a network of local Pharma companies, hospitals and clinical labs, the new Joint Venture will introduce into India an innovative site‐directed microsequencing platform that combines ease of use, specifity and cost competitiveness, allowing the introduction of companion diagnostics to one of the biggest global Healthcare markets.
Most read news
Organizations
Other news from the department business & finance
These products might interest you
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.